Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

Incyte Corporation (INCY)

-NasdaqGS
88.98 Down 0.29(0.32%) Sep 23, 4:00PM EDT
|After Hours : 88.98 0.00 (0.00%) Sep 23, 4:47PM EDT
Prev Close:89.27
Open:88.39
Bid:87.01 x 100
Ask:91.50 x 600
1y Target Est:98.71
Beta:1.18664
Earnings Date:Nov 1 - Nov 7 (Est.)
Day's Range:88.39 - 91.26
52wk Range:55.00 - 131.33
Volume:1,339,735
Avg Vol (3m):1,164,420
Market Cap:16.73B
P/E (ttm):241.79
EPS (ttm):0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 0.32%16.73B
CELGDown 1.03%84.82B
AMGNDown 0.47%130.81B

Key Statistics

Forward P/E (1 yr):65.43
P/S (ttm):17.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.18
Quarterly EPS Est (Sep-16) :-0.04
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):8.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback